PhenoVista Biosciences Raises Growth Capital From BroadOak Capital Partners
SAN DIEGO--(BUSINESS WIRE)--PhenoVista Biosciences announced today that it has secured funding from BroadOak Capital Partners, a life science-focused investor. Since its founding in 2014, PhenoVista has democratized access to high-content analysis of physiologically relevant cell models. The investment will be used to develop new complex products, such as models of…